These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25219798)

  • 1. Construction of a chimeric lysin Ply187N-V12C with extended lytic activity against staphylococci and streptococci.
    Dong Q; Wang J; Yang H; Wei C; Yu J; Zhang Y; Huang Y; Zhang XE; Wei H
    Microb Biotechnol; 2015 Mar; 8(2):210-20. PubMed ID: 25219798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered Lysins With Customized Lytic Activities Against Enterococci and Staphylococci.
    Binte Muhammad Jai HS; Dam LC; Tay LS; Koh JJW; Loo HL; Kline KA; Goh BC
    Front Microbiol; 2020; 11():574739. PubMed ID: 33324362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phage lysin LysK can be truncated to its CHAP domain and retain lytic activity against live antibiotic-resistant staphylococci.
    Horgan M; O'Flynn G; Garry J; Cooney J; Coffey A; Fitzgerald GF; Ross RP; McAuliffe O
    Appl Environ Microbiol; 2009 Feb; 75(3):872-4. PubMed ID: 19047377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploiting Broad-Spectrum Chimeric Lysin to Cooperate with Mupirocin against Staphylococcus aureus-Induced Skin Infections and Delay the Development of Mupirocin Resistance.
    Duan XC; Li XX; Li XM; Wang S; Zhang FQ; Qian P
    Microbiol Spectr; 2023 Jun; 11(3):e0505022. PubMed ID: 37125939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and characterization of a chimeric lysin ClyV with improved bactericidal activity against Streptococcus agalactiae in vitro and in vivo.
    Huang L; Luo D; Gondil VS; Gong Y; Jia M; Yan D; He J; Hu S; Yang H; Wei H
    Appl Microbiol Biotechnol; 2020 Feb; 104(4):1609-1619. PubMed ID: 31900556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antibacterial activity of E. coli bacteriophage lysin lysep3 is enhanced by fusing the Bacillus amyloliquefaciens bacteriophage endolysin binding domain D8 to the C-terminal region.
    Wang S; Gu J; Lv M; Guo Z; Yan G; Yu L; Du C; Feng X; Han W; Sun C; Lei L
    J Microbiol; 2017 May; 55(5):403-408. PubMed ID: 28124780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dissection of phage lysin PlySs2: integrity of the catalytic and cell wall binding domains is essential for its broad lytic activity.
    Huang Y; Yang H; Yu J; Wei H
    Virol Sin; 2015 Feb; 30(1):45-51. PubMed ID: 25680444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A chimeolysin with extended-spectrum streptococcal host range found by an induced lysis-based rapid screening method.
    Yang H; Linden SB; Wang J; Yu J; Nelson DC; Wei H
    Sci Rep; 2015 Nov; 5():17257. PubMed ID: 26607832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The N-terminal and central domain of colicin A enables phage lysin to lyse Escherichia coli extracellularly.
    Yan G; Liu J; Ma Q; Zhu R; Guo Z; Gao C; Wang S; Yu L; Gu J; Hu D; Han W; Du R; Yang J; Lei L
    Antonie Van Leeuwenhoek; 2017 Dec; 110(12):1627-1635. PubMed ID: 28730370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 1.6 A crystal structure of the catalytic domain of PlyB, a bacteriophage lysin active against Bacillus anthracis.
    Porter CJ; Schuch R; Pelzek AJ; Buckle AM; McGowan S; Wilce MC; Rossjohn J; Russell R; Nelson D; Fischetti VA; Whisstock JC
    J Mol Biol; 2007 Feb; 366(2):540-50. PubMed ID: 17182056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EC300: a phage-based, bacteriolysin-like protein with enhanced antibacterial activity against Enterococcus faecalis.
    Proença D; Leandro C; Garcia M; Pimentel M; São-José C
    Appl Microbiol Biotechnol; 2015 Jun; 99(12):5137-49. PubMed ID: 25728445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial activity of everninomicin against clinical isolates of Enterococcus spp., Staphylococcus spp., and Streptococcus spp. tested by Etest.
    Terakubo S; Takemura H; Yamamoto H; Ikejima H; Kunishima H; Kanemitsu K; Kaku M; Shimada J
    J Infect Chemother; 2001 Dec; 7(4):263-6. PubMed ID: 11810596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic properties of a phage-induced lysin affecting group A streptococci.
    DOUGHTY CC; HAYASHI JA
    J Bacteriol; 1962 May; 83(5):1058-68. PubMed ID: 13887529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LambdaSa1 and LambdaSa2 prophage lysins of Streptococcus agalactiae.
    Pritchard DG; Dong S; Kirk MC; Cartee RT; Baker JR
    Appl Environ Microbiol; 2007 Nov; 73(22):7150-4. PubMed ID: 17905888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a bacteriophage lysin (Ply700) from Streptococcus uberis.
    Celia LK; Nelson D; Kerr DE
    Vet Microbiol; 2008 Jul; 130(1-2):107-17. PubMed ID: 18242012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a broadly active phage lytic enzyme with lethal activity against antibiotic-resistant Enterococcus faecalis and Enterococcus faecium.
    Yoong P; Schuch R; Nelson D; Fischetti VA
    J Bacteriol; 2004 Jul; 186(14):4808-12. PubMed ID: 15231813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CELL-WALL LYSINS OF STAPHYLOCOCCUS AUREUS STRAINS INDUCED BY SPECIFIC TYPING PHAGES.
    RALSTON DJ; MCIVOR M
    J Bacteriol; 1964 Sep; 88(3):667-75. PubMed ID: 14208505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus.
    Gilmer DB; Schmitz JE; Euler CW; Fischetti VA
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2743-50. PubMed ID: 23571534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of a new cephalosporin, RWJ-54428, against streptococci, enterococci and staphylococci, including glycopeptide-intermediate Staphylococcus aureus.
    Swenson JM; Tenover FC
    J Antimicrob Chemother; 2002 May; 49(5):845-50. PubMed ID: 12003982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bifunctional peptidoglycan lysin of Streptococcus agalactiae bacteriophage B30.
    Pritchard DG; Dong S; Baker JR; Engler JA
    Microbiology (Reading); 2004 Jul; 150(Pt 7):2079-2087. PubMed ID: 15256551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.